Stockreport

Vaccinex Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Vaccinex, Inc.  (VCNX) 
PDF Patients are currently being screened and enrolled in two studies of pepinemab as monotherapy in Alzheimer’s disease and in combination with KEYTRUDA® in Metastatic Head [Read more]